Psoriasis is traditionally defined as an inflammatory chronic--relapsing disease of the skin. It is also -- as widely demonstrated -- a disease associated with multiple comorbidities: arthropathy, inflammatory bowel disease, metabolic, cardiovascular, ocular and psychological disorders. The disease also has a significant impact on patients' quality of life, whose work ability decreases considerably with clear consequences for the social costs. Therefore, if we consider that in Tuscany, more than 100,000 people out of 3,672,202 suffer from psoriasis, it is of paramount importance focusing the attention on a rational model of clinical and therapeutic management of the disease.
|Autori:||Prignano, F; Tripo, L; Amato, L; Bagnoni, G; Bartoli, L; Battistini, S; Bellini, M; Brandini, L; Caproni, M; Cardinali, C; Castelli, A; Cecchi, R; Cervadoro, Gregorio; Dini, Valentina; Fimiani, M; Eberle, O; Fabbri, P; Lo Scocco, G; Martini, P; Marsili, F; Mazzatenta, C; Niccoli, M. C; Peccianti, C; Pellegrino, M; Romanelli, Marco; Sirna, R; Taviti, F; Volpi, V; Pimpinelli, N.|
|Titolo:||Tuscan consensus for the diagnosis, treatment and follow-up of moderate-to-severe psoriasis|
|Anno del prodotto:||2017|
|Digital Object Identifier (DOI):||10.23736/S0392-0488.16.05005-7|
|Appare nelle tipologie:||1.1 Articolo in rivista|